Michele M Spence

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit
    Michele M Spence
    Kaiser Permanente, 12254 Bellflower Blvd, Downey, CA 90242, USA
    J Manag Care Pharm 12:377-82. 2006
  2. ncbi Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease
    Michele M Spence
    Kaiser Permanente Southern California, 12254 Bellflower Blvd, Downey, CA 90242, USA
    J Manag Care Pharm 20:1036-45. 2014
  3. doi Risk of injury associated with skeletal muscle relaxant use in older adults
    Michele M Spence
    Pharmacy Outcomes Research Group, Kaiser Permanente, Downey, CA, USA
    Ann Pharmacother 47:993-8. 2013
  4. doi Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system
    Michele M Spence
    Pharmacy Outcomes Research Group, Kaiser Permanente, Downey, California 90242, USA
    Pharmacotherapy 32:981-7. 2012
  5. ncbi Evaluation of a pharmacist-managed amiodarone monitoring program
    Michele M Spence
    Kaiser Permanente, Pharmacy Outcomes Research Group, 12254 Bellflower Blvd, Downey, CA 90242, USA
    J Manag Care Pharm 17:513-22. 2011
  6. doi Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid
    Michele M Spence
    Pharmacy Outcomes Research Group, Kaiser Permanente, Downey, CA, USA
    Ann Pharmacother 44:1384-8. 2010
  7. pmc Effect of cost-sharing changes on self-monitoring of blood glucose
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, CA 94612, USA
    Am J Manag Care 13:408-16. 2007
  8. ncbi Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids
    James Chan
    Pharmacy Outcomes Research Group, Kaiser Permanente Medical Care Program, 1800 Harrison, 13th Fl, Oakland, CA 94612, USA
    J Manag Care Pharm 13:21-7. 2007
  9. pmc Longitudinal study of new and prevalent use of self-monitoring of blood glucose
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, CA 94612, USA
    Diabetes Care 29:1757-63. 2006
  10. ncbi Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing
    Michele M Spence
    Kaiser Permanente, USA
    Med Care Res Rev 62:544-59. 2005

Detail Information

Publications10

  1. ncbi Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit
    Michele M Spence
    Kaiser Permanente, 12254 Bellflower Blvd, Downey, CA 90242, USA
    J Manag Care Pharm 12:377-82. 2006
    ..Generic-only pharmacy benefits may present more of a burden to patients with chronic disease conditions such as chronic obstructive pulmonary disease (COPD), where generic drug therapy choices are more limited...
  2. ncbi Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease
    Michele M Spence
    Kaiser Permanente Southern California, 12254 Bellflower Blvd, Downey, CA 90242, USA
    J Manag Care Pharm 20:1036-45. 2014
    ....
  3. doi Risk of injury associated with skeletal muscle relaxant use in older adults
    Michele M Spence
    Pharmacy Outcomes Research Group, Kaiser Permanente, Downey, CA, USA
    Ann Pharmacother 47:993-8. 2013
    ..SMRs continue to be used among older adults, although they are on the Beers list as drugs to avoid in the elderly...
  4. doi Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system
    Michele M Spence
    Pharmacy Outcomes Research Group, Kaiser Permanente, Downey, California 90242, USA
    Pharmacotherapy 32:981-7. 2012
    ..To evaluate clinical and safety outcomes among transplant recipients whose tacrolimus was converted from the brand-name formulation to a generic formulation...
  5. ncbi Evaluation of a pharmacist-managed amiodarone monitoring program
    Michele M Spence
    Kaiser Permanente, Pharmacy Outcomes Research Group, 12254 Bellflower Blvd, Downey, CA 90242, USA
    J Manag Care Pharm 17:513-22. 2011
    ..However, laboratory and pulmonary monitoring rates have been found to be substantially lower than recommended in guidelines, including those of the North American Society of Pacing and Electrophysiology (NASPE, 2007)...
  6. doi Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid
    Michele M Spence
    Pharmacy Outcomes Research Group, Kaiser Permanente, Downey, CA, USA
    Ann Pharmacother 44:1384-8. 2010
    ..There have been no head-to-head clinical trials comparing pamidronate and zoledronic acid among patients with advanced prostate cancer...
  7. pmc Effect of cost-sharing changes on self-monitoring of blood glucose
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, CA 94612, USA
    Am J Manag Care 13:408-16. 2007
    ..To study the effect of cost-sharing policy changes on utilization of test strips for self-monitoring of blood glucose...
  8. ncbi Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids
    James Chan
    Pharmacy Outcomes Research Group, Kaiser Permanente Medical Care Program, 1800 Harrison, 13th Fl, Oakland, CA 94612, USA
    J Manag Care Pharm 13:21-7. 2007
    ....
  9. pmc Longitudinal study of new and prevalent use of self-monitoring of blood glucose
    Andrew J Karter
    Division of Research, Kaiser Permanente, Oakland, CA 94612, USA
    Diabetes Care 29:1757-63. 2006
    ..We sought to assess longitudinal association between self-monitoring of blood glucose (SMBG) and glycemic control in diabetic patients from an integrated health plan (Kaiser Permanente Northern California)...
  10. ncbi Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing
    Michele M Spence
    Kaiser Permanente, USA
    Med Care Res Rev 62:544-59. 2005
    ..Findings also suggest that some patients may benefit from DTCA. The authors discuss the need for balanced drug information for consumers, increased physician vigilance in prescribing appropriately, and further study of DTCA...